Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fumito Wada
Observed names:
F. Wada,
Wada, Fumito,
ワダ, フミト
Institution:
National Cerebral and Cardiovascular Center Research Institute
Observed institutions:
National Cerebral and Cardiovascular Center,
National Cerebral and Cardiovascular Center Research Institute,
Open Innovation Center, National Cerebral and Cardiovascular Center,
The University of Osaka
ORCID:
0000-0001-6978-1894
Observed ORCID:
0000-0001-6978-1894
OpenAlex ID:
A5060073885
Works
32
Awards
1
Amido-bridged nucleic acids with small hydrophobic residues enhance hepatic tropism of antisense oligonucleotides in vivo
2015
·
Tsuyoshi Yamamoto
, Aiko Yahara
, et al.
·
Organic & Biomolecular Chemistry
·
53
Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides
2016
·
Shunsuke Wada
, Hidenori Yasuhara
, et al.
·
Journal of Controlled Release
·
51
Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides
2015
·
Tsuyoshi Yamamoto
, Motoki Sawamura
, et al.
·
Bioorganic & Medicinal Chemistry
·
49
Ca2+enrichment in culture medium potentiates effect of oligonucleotides
2015
·
Shin-ichiro Hori
, Tsuyoshi Yamamoto
, et al.
·
Nucleic Acids Research
·
45
PDF
Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes
2017
·
Kiyoko Setoguchi
, Lin Cui
, et al.
·
Molecular Therapy — Nucleic Acids
·
42
Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
2021
·
Tsuyoshi Yamamoto
, Yahiro Mukai
, et al.
·
Pharmaceutics
·
26
PDF
Evaluation of Multiple-Turnover Capability of Locked Nucleic Acid Antisense Oligonucleotides in Cell-Free RNase H-Mediated Antisense Reaction and in Mice
2014
·
Tsuyoshi Yamamoto
, Naoko Fujii
, et al.
·
Nucleic Acid Therapeutics
·
26
Superior Silencing by 2′,4′-BNANC-Based Short Antisense Oligonucleotides Compared to 2′,4′-BNA/LNA-Based Apolipoprotein B Antisense Inhibitors
2012
·
Tsuyoshi Yamamoto
, Hidenori Yasuhara
, et al.
·
Journal of Nucleic Acids
·
26
PDF
Cholesterol–GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides
2018
·
Fumito Wada
, Tsuyoshi Yamamoto
, et al.
·
Nucleic Acid Therapeutics
·
24
Development of Antisense Drugs for Dyslipidemia
2016
·
Tsuyoshi Yamamoto
, Fumito Wada
, et al.
·
Journal of Atherosclerosis and Thrombosis
·
18
PDF
Triazole- and Tetrazole-Bridged Nucleic Acids: Synthesis, Duplex Stability, Nuclease Resistance, and in Vitro and in Vivo Antisense Potency
2016
·
Yasunori Mitsuoka
, Tsuyoshi Yamamoto
, et al.
·
The Journal of Organic Chemistry
·
17
Synthesis, duplex-forming ability, enzymatic stability, and in vitro antisense potency of oligonucleotides including 2′-C,4′-C-ethyleneoxy-bridged thymidine derivatives
2017
·
Takashi Osawa
, Motoki Sawamura
, et al.
·
Organic & Biomolecular Chemistry
·
16
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
2021
·
Fumito Wada
, Tsuyoshi Yamamoto
, et al.
·
Molecular Therapy — Nucleic Acids
·
11
PDF
Effective gene silencing activity of prodrug-type 2′-O-methyldithiomethyl siRNA compared with non-prodrug-type 2′-O-methyl siRNA
2018
·
Junsuke Hayashi
, Misa Nishigaki
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
11
Locked nucleic acid antisense inhibitor targeting apolipoprotein C-III efficiently and preferentially removes triglyceride from large very low-density lipoprotein particles in murine plasma
2013
·
Tsuyoshi Yamamoto
, Satoshi Obika
, et al.
·
European Journal of Pharmacology
·
11
Effect of modular conjugation strategy forN-acetylgalactosamine-targeted antisense oligonucleotides
2019
·
Tsuyoshi Yamamoto
, Motoki Sawamura
, et al.
·
Nucleosides Nucleotides & Nucleic Acids
·
7
Prodrug‐Type Phosphotriester Oligonucleotides with Linear Disulfide Promoieties Responsive to Reducing Environment
2023
·
Norihito Sugimoto
, Junsuke Hayashi
, et al.
·
ChemBioChem
·
5
PDF
Programmed Instability of Ligand Conjugation Manifold for Efficient Hepatocyte Delivery of Therapeutic Oligonucleotides
2021
·
Chisato Terada
, Fumito Wada
, et al.
·
Nucleic Acid Therapeutics
·
5
Calcium-Mediated In Vitro Transfection Technique of Oligonucleotides with Broad Chemical Modification Compatibility
2020
·
Fumito Wada
, Shin-ichiro Hori
, et al.
·
Methods in molecular biology
·
4
Effect of an N-substituent in sulfonamide-bridged nucleic acid (SuNA) on hybridization ability and duplex structure
2016
·
Yasunori Mitsuoka
, Hiroshi Aoyama
, et al.
·
Organic & Biomolecular Chemistry
·
4
Rational design of prodrug-type apoB-targeted siRNA for nuclease resistance improvement without compromising gene silencing potency
2024
·
Junsuke Hayashi
, Yosuke Ochi
, et al.
·
Bioorganic & Medicinal Chemistry
·
1
Development of APOC3 antisense oligonucleotide for broader dyslipidemia
2024
·
Mariko Harada-Shiba
, Tsuyoshi Yamamoto
, et al.
·
Atherosclerosis
PDF
Development of antisense drug targeting PCSK9
2018
·
M. Harada-Shiba
, F. Wada
, et al.
·
Atherosclerosis
Preclinical Pharmacology and Safety Studies of GalNAc-conjugated Antisense Oligonucleotides Targeting Human PCSK9
2018
·
Fumito Wada
, Tsuyoshi Yamamoto
, et al.
·
Atherosclerosis Supplements
Abstract 18674: Development of Antisense Drug Targeting PCSK9
2017
·
Mariko Harada‐Shiba
, Fumito Wada
, et al.
·
Circulation
Show more works
View as search
Works count:
32
Citation count:
452
H-index:
12
I10-index:
15
Year
Topic
Type